Oncology
Become a Member Today!
Email
Password
Remember me
Forgot your Password?

Invite Code?


Article ID

Home
General Oncology
Messages
Conferences
Jobs
Newsletters
My Library
Topics in
Oncology
        Alternative Therapies
        Anemia/Polycythemia
        BMT/SCT
        Basic Science/Genetics
        Bone/Cartilage
        Breast
        Carcinogenesis
        Coagulation/Bleeding Dz
        Colorectal Cancer/Polyps
        Dermatologic Oncology
        Diagnostics/Radiology
        Economics of Medicine
        Endocrine Oncology
        GI Oncology
        Gynecologic Oncology
        Head and Neck
        Hepatobiliary/Pancreas
        Leukemia/Lymphoma
        Lung/Thoracic Oncology
        Myeloproliferative Dz
        Neurologic Oncology
        Pain Management/
    Palliative Care
        Pediatric Heme/Oncology
        Pharmacology/Therapy
        Popular Press
        Renal/Urologic
        Side Effects
        Soft Tissue/Sarcoma
        Transfusion Medicine
 
Help
Resource Center
RSS News Feeds
Send Newsletter
to a Friend
Top Ten Searches
brca1  brca1
prostate-specific antigen  prostate-specific antigen
sclc  sclc
fobt  fobt
egd  egd
bmi  bmi
dysplasia  dysplasia
hematologic  hematologic
ovarian  ovarian
hcc  hcc
 
Sponsor

Your Unread Messages

Technology Advances: Nanotech PSA Levels Unmask Lingering Prostate Cancer
Dorothy J. Schirf, MD, MDLinx Oncology
Need help assessing patients for generic risk factors for hemophilia? Check out our free CME, fresh from ISTH 2009.
Victoria Luken, MDLinx CME
FDA Update: New Vaccine Approved for Cervical Cancer
Tracy Hampton, PhD, MDLinx Oncology
  See all

Articles: Side Effects



Latest (3) Month's Top Read  
Receive free subspecialty "5-minute updates" via email
Casopitant improves the quality of life in patients receiving highly emetogenic chemotherapy
Supportive Care in Cancer, 11/06/09
Sponsor
Rare incidence of congestive heart failure in gastrointestinal stromal tumor and other sarcoma patients receiving imatinib mesylate
Cancer, 11/06/09
A Throbbing Pain in the Head: Trastuzumab-induced Migraine
Anticancer Research, 11/06/09

Prior Articles


Procalcitonin as a predictive marker of infections in chemoinduced neutropenia
Journal of Cancer Research & Clinical Oncology, 11/05/09
Interstitial pneumonia arising in a patient treated with oxaliplatin, 5-fluorouracil, and, leucovorin (FOLFOX)
International Journal of Clinical Oncology, 10/30/09
Methotrexate-induced myelopathy responsive to substitution of multiple folate metabolites
Journal of Neuro-Oncology, 10/30/09
Oxaliplatin-induced allergic reaction in patients with colorectal cancer in Japan
International Journal of Clinical Oncology, 10/30/09
Influence of the polymorphism in candidate genes on late cardiac damage in patients treated due to acute leukemia in childhood
Leukemia and Lymphoma, 10/30/09
Preliminary characterization of oral lesions associated with inhibitors of mammalian target of rapamycin in cancer patients
Cancer, 10/29/09
Acute pulmonary failure during remission induction chemotherapy in adults with acute myeloid leukemia or high-risk myelodysplastic syndrome
Cancer, 10/29/09
Tamoxifen and arrhythmia
Medical Oncology, 10/28/09
Intracranial tumor lysis and cerebral edema after administration of intrathecal methotrexate: a case report and discussion
Medical Oncology, 10/28/09
Long-Term Evaluation of Ifosfamide-Related Nephrotoxicity in Children
Journal of Clinical Oncology, 10/26/09
Myelosuppression and kinase selectivity of multikinase angiogenesis inhibitors
British Journal of Cancer, 10/26/09
Clinically Driven Diagnostic Antifungal Approach in Neutropenic Patients: A Prospective Feasibility Study
Journal of Clinical Oncology, 10/23/09
Efficacious but insidious: A retrospective analysis of fludarabine-induced myelotoxicity using long-term culture?initiating cells in 100 follicular lymphoma patients
Experimental Hematology, 10/22/09
Mucositis: The impact, biology and therapeutic opportunities of oral mucositis
Oral Oncology, 10/21/09
Phase 2 trial results with the novel neurokinin-1 receptor antagonist casopitant in combination with ondansetron and dexamethasone for the prevention of chemotherapy-induced nausea and vomiting in cancer patients receiving moderately emetogenic chemotherapy
Cancer, 10/20/09
Impact of radiation and chemotherapy on risk of dental abnormalities
Cancer, 10/20/09
UGT1A1 genotyping: a predictor of irinotecan-associated side effects and drug efficacy
Anti-Cancer Drugs, 10/19/09

Receive free subspecialty "5-minute updates" via email
Indexed Journals: Journal of Clinical Oncology, Cancer Research, Annals Oncology more...
213 Available Pages
1      2      3      4      5      6      7      8      9      10      Next      Last
Sponsor

Read a Different Specialty

Allergy/Immunology
Anesthesiology
Cardiology
Dermatology
Drugs
Emergency Medicine
Endocrinology
ENT
Family Medicine
Gastroenterology
Hematology-Oncology
Infectious Disease
Internal Medicine
Nephrology
Neurology
OB/Gyn
Ophthalmology
Orthopedics
Pain
Pediatrics
Practice Management
Psychiatry
Pulmonology
Radiology
Rheumatology
Surgery
Urology

Profession Index

Dentist
Hospital Administrator
Nurse
    Medical Students
Nurse Practitioner
Pharma/Drug Marketer
    Pharmacist
Physician Assistants
Article Search
Keyword:
Search:
Published within:
Sort By:
Date Relevance
    
Sponsor
Sponsor
About MDLinx  |  Contact  |  Advertise with MDLinx  |  Site Map  |  Privacy Policy  |  Terms of Use  |  Sign Up For Newsletters  |  Recommend this Site

English |  Español |  Français |  Deutsch |  中文 |  Руccкий |  Norsk |  Nederlands |  Português |  Italiano

©1999-2009 MDLinx, Inc.